VistaPharm LLC recalls Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distribu
Recalled September 20, 2023 · FDA recall D-1149-2023 · VistaPharm
Hazard
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results · FDA Class II
Units
14,400 bottles
Sold at
Distributed nationwide to 68 consignees in the U.S.
Description
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Product
Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16
Manufacturer(s)
VistaPharm LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →